Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors? We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

This eBook explores the latest advances in iPSC-derived models, highlighting how they bridge preclinical and clinical ...

Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201 SLNB is a well-tolerated, minimally invasive ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...